HEADER MOTOR PROTEIN 03-OCT-16 5M05 TITLE CHICKEN SMOOTH MUSCLE MYOSIN MOTOR DOMAIN CO-CRYSTALLIZED WITH THE TITLE 2 SPECIFIC CK-571 INHIBITOR, MGADP FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYOSIN-11; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MYOSIN HEAVY CHAIN 11,MYOSIN HEAVY CHAIN,GIZZARD SMOOTH COMPND 5 MUSCLE; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031; SOURCE 5 GENE: MYH11; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS MYOSIN INHIBITOR, MOTOR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.SIRIGU,J.HARTMAN,A.HOUDUSSE REVDAT 5 17-JAN-24 5M05 1 LINK REVDAT 4 06-SEP-17 5M05 1 REMARK REVDAT 3 18-JAN-17 5M05 1 TITLE REVDAT 2 14-DEC-16 5M05 1 JRNL REVDAT 1 16-NOV-16 5M05 0 JRNL AUTH S.SIRIGU,J.J.HARTMAN,V.J.PLANELLES-HERRERO,V.ROPARS, JRNL AUTH 2 S.CLANCY,X.WANG,G.CHUANG,X.QIAN,P.P.LU,E.BARRETT,K.RUDOLPH, JRNL AUTH 3 C.ROYER,B.P.MORGAN,E.A.STURA,F.I.MALIK,A.M.HOUDUSSE JRNL TITL HIGHLY SELECTIVE INHIBITION OF MYOSIN MOTORS PROVIDES THE JRNL TITL 2 BASIS OF POTENTIAL THERAPEUTIC APPLICATION. JRNL REF PROC. NATL. ACAD. SCI. V. 113 E7448 2016 JRNL REF 2 U.S.A. JRNL REFN ESSN 1091-6490 JRNL PMID 27815532 JRNL DOI 10.1073/PNAS.1609342113 REMARK 2 REMARK 2 RESOLUTION. 2.68 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.2_1309 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.68 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.68 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.020 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 28992 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1451 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.6902 - 5.7595 1.00 2963 156 0.1669 0.2082 REMARK 3 2 5.7595 - 4.5725 1.00 2815 149 0.1625 0.2218 REMARK 3 3 4.5725 - 3.9948 1.00 2793 145 0.1515 0.2247 REMARK 3 4 3.9948 - 3.6297 1.00 2790 148 0.1762 0.1977 REMARK 3 5 3.6297 - 3.3696 1.00 2753 143 0.1996 0.2720 REMARK 3 6 3.3696 - 3.1710 1.00 2749 148 0.2191 0.2883 REMARK 3 7 3.1710 - 3.0122 1.00 2735 143 0.2337 0.3259 REMARK 3 8 3.0122 - 2.8811 1.00 2754 143 0.2358 0.3256 REMARK 3 9 2.8811 - 2.7702 1.00 2713 145 0.2459 0.3101 REMARK 3 10 2.7702 - 2.6746 0.90 2476 131 0.2587 0.3385 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.360 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 5833 REMARK 3 ANGLE : 1.243 7873 REMARK 3 CHIRALITY : 0.078 869 REMARK 3 PLANARITY : 0.005 1015 REMARK 3 DIHEDRAL : 18.785 2190 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5M05 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1200001657. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.980110 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 10.9.4 REMARK 200 DATA SCALING SOFTWARE : XSCALE 10.90.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29000 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.670 REMARK 200 RESOLUTION RANGE LOW (A) : 49.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.67 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 0.80000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.970 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 6.4.0 REMARK 200 STARTING MODEL: 1BR1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8K, 50 MM BICINE PH 8.2, 10% DMSO, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 36.59500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 101.48500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.59500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 101.48500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 GLN A 3 REMARK 465 LYS A 4 REMARK 465 PRO A 5 REMARK 465 LEU A 6 REMARK 465 SER A 7 REMARK 465 ASP A 8 REMARK 465 ASP A 9 REMARK 465 GLU A 10 REMARK 465 LYS A 11 REMARK 465 PHE A 12 REMARK 465 LEU A 13 REMARK 465 PHE A 14 REMARK 465 VAL A 15 REMARK 465 ASP A 16 REMARK 465 LYS A 17 REMARK 465 ASN A 18 REMARK 465 PHE A 19 REMARK 465 VAL A 20 REMARK 465 ASN A 21 REMARK 465 ASN A 22 REMARK 465 PRO A 23 REMARK 465 LEU A 24 REMARK 465 ALA A 25 REMARK 465 GLN A 26 REMARK 465 ALA A 27 REMARK 465 ASP A 28 REMARK 465 TRP A 29 REMARK 465 SER A 30 REMARK 465 ALA A 31 REMARK 465 LYS A 32 REMARK 465 HIS A 201 REMARK 465 LYS A 202 REMARK 465 GLY A 203 REMARK 465 LYS A 204 REMARK 465 ARG A 205 REMARK 465 THR A 206 REMARK 465 PRO A 207 REMARK 465 ALA A 208 REMARK 465 SER A 209 REMARK 465 LEU A 210 REMARK 465 LYS A 211 REMARK 465 VAL A 212 REMARK 465 HIS A 213 REMARK 465 LEU A 214 REMARK 465 PHE A 215 REMARK 465 GLN A 574 REMARK 465 LEU A 575 REMARK 465 LYS A 576 REMARK 465 VAL A 628 REMARK 465 ASP A 629 REMARK 465 ARG A 630 REMARK 465 ILE A 631 REMARK 465 VAL A 632 REMARK 465 GLY A 633 REMARK 465 LEU A 634 REMARK 465 ASP A 635 REMARK 465 GLN A 636 REMARK 465 MET A 637 REMARK 465 ALA A 638 REMARK 465 LYS A 639 REMARK 465 MET A 640 REMARK 465 THR A 641 REMARK 465 GLU A 642 REMARK 465 SER A 643 REMARK 465 SER A 644 REMARK 465 LEU A 645 REMARK 465 PRO A 646 REMARK 465 SER A 647 REMARK 465 ALA A 648 REMARK 465 SER A 649 REMARK 465 LYS A 650 REMARK 465 THR A 651 REMARK 465 LYS A 652 REMARK 465 LYS A 653 REMARK 465 GLY A 654 REMARK 465 MET A 655 REMARK 465 PHE A 656 REMARK 465 ARG A 788 REMARK 465 ASP A 789 REMARK 465 LEU A 790 REMARK 465 GLY A 791 REMARK 465 SER A 792 REMARK 465 ASP A 793 REMARK 465 TYR A 794 REMARK 465 LYS A 795 REMARK 465 ASP A 796 REMARK 465 ASP A 797 REMARK 465 ASP A 798 REMARK 465 ASP A 799 REMARK 465 LYS A 800 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 448 CD CE NZ REMARK 470 LYS A 452 CG CD CE NZ REMARK 470 THR A 453 OG1 CG2 REMARK 470 LYS A 573 CA REMARK 470 ARG A 657 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 736 CG1 CG2 CD1 REMARK 470 LYS A 744 CG CD CE NZ REMARK 470 LYS A 758 CG CD CE NZ REMARK 470 GLU A 787 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O33 52E A 901 O HOH A 1001 2.08 REMARK 500 NH1 ARG A 107 O TYR A 114 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD1 ASN A 372 NH1 ARG A 706 4455 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 534 C - N - CA ANGL. DEV. = -16.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 51 143.48 -179.81 REMARK 500 LYS A 53 74.74 174.85 REMARK 500 ASN A 64 17.25 -146.33 REMARK 500 PRO A 131 30.96 -75.44 REMARK 500 TYR A 217 -72.04 78.62 REMARK 500 ASP A 283 -3.51 73.19 REMARK 500 GLU A 308 41.35 -149.54 REMARK 500 VAL A 409 25.39 -142.04 REMARK 500 ALA A 411 80.21 -62.34 REMARK 500 ALA A 412 -177.29 85.67 REMARK 500 LYS A 454 12.08 52.01 REMARK 500 SER A 476 -161.37 -111.44 REMARK 500 ILE A 510 117.19 69.06 REMARK 500 GLU A 511 61.14 110.36 REMARK 500 THR A 532 -148.97 -135.04 REMARK 500 ASN A 533 -105.33 59.32 REMARK 500 SER A 572 96.23 -58.77 REMARK 500 LYS A 626 4.09 -62.63 REMARK 500 ASN A 676 36.69 -93.44 REMARK 500 GLN A 719 42.94 -79.20 REMARK 500 GLN A 732 27.81 -77.31 REMARK 500 ILE A 736 -74.60 -49.71 REMARK 500 ALA A 738 72.30 -153.74 REMARK 500 PRO A 764 -9.00 -56.12 REMARK 500 GLU A 786 -91.09 -116.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE A 510 GLU A 511 30.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 902 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 184 OG1 REMARK 620 2 SER A 246 OG 94.3 REMARK 620 3 ADP A 903 O2B 97.6 164.9 REMARK 620 4 HOH A1003 O 92.7 91.8 78.3 REMARK 620 5 HOH A1025 O 176.9 82.8 85.1 86.3 REMARK 620 6 HOH A1042 O 99.4 91.6 95.6 167.1 81.8 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 52E A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ADP A 903 DBREF 5M05 A 1 790 UNP P10587 MYH11_CHICK 1 790 SEQADV 5M05 ALA A 2 UNP P10587 SER 2 CONFLICT SEQADV 5M05 ARG A 205 UNP P10587 LYS 205 CONFLICT SEQADV 5M05 THR A 206 UNP P10587 ASP 206 CONFLICT SEQADV 5M05 PRO A 207 UNP P10587 THR 207 CONFLICT SEQADV 5M05 ALA A 208 UNP P10587 SER 208 CONFLICT SEQADV 5M05 SER A 209 UNP P10587 ILE 209 CONFLICT SEQADV 5M05 LEU A 210 UNP P10587 THR 210 CONFLICT SEQADV 5M05 LYS A 211 UNP P10587 GLN 211 CONFLICT SEQADV 5M05 VAL A 212 UNP P10587 GLY 212 CONFLICT SEQADV 5M05 HIS A 213 UNP P10587 PRO 213 CONFLICT SEQADV 5M05 LEU A 214 UNP P10587 SER 214 CONFLICT SEQADV 5M05 PRO A 216 UNP P10587 SER 216 CONFLICT SEQADV 5M05 ALA A 411 UNP P10587 ARG 411 CONFLICT SEQADV 5M05 ALA A 412 UNP P10587 ASP 412 CONFLICT SEQADV 5M05 GLU A 415 UNP P10587 GLN 415 CONFLICT SEQADV 5M05 GLY A 791 UNP P10587 EXPRESSION TAG SEQADV 5M05 SER A 792 UNP P10587 EXPRESSION TAG SEQADV 5M05 ASP A 793 UNP P10587 EXPRESSION TAG SEQADV 5M05 TYR A 794 UNP P10587 EXPRESSION TAG SEQADV 5M05 LYS A 795 UNP P10587 EXPRESSION TAG SEQADV 5M05 ASP A 796 UNP P10587 EXPRESSION TAG SEQADV 5M05 ASP A 797 UNP P10587 EXPRESSION TAG SEQADV 5M05 ASP A 798 UNP P10587 EXPRESSION TAG SEQADV 5M05 ASP A 799 UNP P10587 EXPRESSION TAG SEQADV 5M05 LYS A 800 UNP P10587 EXPRESSION TAG SEQRES 1 A 800 MET ALA GLN LYS PRO LEU SER ASP ASP GLU LYS PHE LEU SEQRES 2 A 800 PHE VAL ASP LYS ASN PHE VAL ASN ASN PRO LEU ALA GLN SEQRES 3 A 800 ALA ASP TRP SER ALA LYS LYS LEU VAL TRP VAL PRO SER SEQRES 4 A 800 GLU LYS HIS GLY PHE GLU ALA ALA SER ILE LYS GLU GLU SEQRES 5 A 800 LYS GLY ASP GLU VAL THR VAL GLU LEU GLN GLU ASN GLY SEQRES 6 A 800 LYS LYS VAL THR LEU SER LYS ASP ASP ILE GLN LYS MET SEQRES 7 A 800 ASN PRO PRO LYS PHE SER LYS VAL GLU ASP MET ALA GLU SEQRES 8 A 800 LEU THR CYS LEU ASN GLU ALA SER VAL LEU HIS ASN LEU SEQRES 9 A 800 ARG GLU ARG TYR PHE SER GLY LEU ILE TYR THR TYR SER SEQRES 10 A 800 GLY LEU PHE CYS VAL VAL ILE ASN PRO TYR LYS GLN LEU SEQRES 11 A 800 PRO ILE TYR SER GLU LYS ILE ILE ASP MET TYR LYS GLY SEQRES 12 A 800 LYS LYS ARG HIS GLU MET PRO PRO HIS ILE TYR ALA ILE SEQRES 13 A 800 ALA ASP THR ALA TYR ARG SER MET LEU GLN ASP ARG GLU SEQRES 14 A 800 ASP GLN SER ILE LEU CYS THR GLY GLU SER GLY ALA GLY SEQRES 15 A 800 LYS THR GLU ASN THR LYS LYS VAL ILE GLN TYR LEU ALA SEQRES 16 A 800 VAL VAL ALA SER SER HIS LYS GLY LYS ARG THR PRO ALA SEQRES 17 A 800 SER LEU LYS VAL HIS LEU PHE PRO TYR GLY GLU LEU GLU SEQRES 18 A 800 LYS GLN LEU LEU GLN ALA ASN PRO ILE LEU GLU ALA PHE SEQRES 19 A 800 GLY ASN ALA LYS THR VAL LYS ASN ASP ASN SER SER ARG SEQRES 20 A 800 PHE GLY LYS PHE ILE ARG ILE ASN PHE ASP VAL THR GLY SEQRES 21 A 800 TYR ILE VAL GLY ALA ASN ILE GLU THR TYR LEU LEU GLU SEQRES 22 A 800 LYS SER ARG ALA ILE ARG GLN ALA LYS ASP GLU ARG THR SEQRES 23 A 800 PHE HIS ILE PHE TYR TYR LEU ILE ALA GLY ALA SER GLU SEQRES 24 A 800 GLN MET ARG ASN ASP LEU LEU LEU GLU GLY PHE ASN ASN SEQRES 25 A 800 TYR THR PHE LEU SER ASN GLY HIS VAL PRO ILE PRO ALA SEQRES 26 A 800 GLN GLN ASP ASP GLU MET PHE GLN GLU THR LEU GLU ALA SEQRES 27 A 800 MET THR ILE MET GLY PHE THR GLU GLU GLU GLN THR SER SEQRES 28 A 800 ILE LEU ARG VAL VAL SER SER VAL LEU GLN LEU GLY ASN SEQRES 29 A 800 ILE VAL PHE LYS LYS GLU ARG ASN THR ASP GLN ALA SER SEQRES 30 A 800 MET PRO ASP ASN THR ALA ALA GLN LYS VAL CYS HIS LEU SEQRES 31 A 800 MET GLY ILE ASN VAL THR ASP PHE THR ARG SER ILE LEU SEQRES 32 A 800 THR PRO ARG ILE LYS VAL GLY ALA ALA VAL VAL GLU LYS SEQRES 33 A 800 ALA GLN THR LYS GLU GLN ALA ASP PHE ALA ILE GLU ALA SEQRES 34 A 800 LEU ALA LYS ALA LYS PHE GLU ARG LEU PHE ARG TRP ILE SEQRES 35 A 800 LEU THR ARG VAL ASN LYS ALA LEU ASP LYS THR LYS ARG SEQRES 36 A 800 GLN GLY ALA SER PHE LEU GLY ILE LEU ASP ILE ALA GLY SEQRES 37 A 800 PHE GLU ILE PHE GLU ILE ASN SER PHE GLU GLN LEU CYS SEQRES 38 A 800 ILE ASN TYR THR ASN GLU LYS LEU GLN GLN LEU PHE ASN SEQRES 39 A 800 HIS THR MET PHE ILE LEU GLU GLN GLU GLU TYR GLN ARG SEQRES 40 A 800 GLU GLY ILE GLU TRP ASN PHE ILE ASP PHE GLY LEU ASP SEQRES 41 A 800 LEU GLN PRO CYS ILE GLU LEU ILE GLU ARG PRO THR ASN SEQRES 42 A 800 PRO PRO GLY VAL LEU ALA LEU LEU ASP GLU GLU CYS TRP SEQRES 43 A 800 PHE PRO LYS ALA THR ASP THR SER PHE VAL GLU LYS LEU SEQRES 44 A 800 ILE GLN GLU GLN GLY ASN HIS ALA LYS PHE GLN LYS SER SEQRES 45 A 800 LYS GLN LEU LYS ASP LYS THR GLU PHE CYS ILE LEU HIS SEQRES 46 A 800 TYR ALA GLY LYS VAL THR TYR ASN ALA SER ALA TRP LEU SEQRES 47 A 800 THR LYS ASN MET ASP PRO LEU ASN ASP ASN VAL THR SER SEQRES 48 A 800 LEU LEU ASN GLN SER SER ASP LYS PHE VAL ALA ASP LEU SEQRES 49 A 800 TRP LYS ASP VAL ASP ARG ILE VAL GLY LEU ASP GLN MET SEQRES 50 A 800 ALA LYS MET THR GLU SER SER LEU PRO SER ALA SER LYS SEQRES 51 A 800 THR LYS LYS GLY MET PHE ARG THR VAL GLY GLN LEU TYR SEQRES 52 A 800 LYS GLU GLN LEU THR LYS LEU MET THR THR LEU ARG ASN SEQRES 53 A 800 THR ASN PRO ASN PHE VAL ARG CYS ILE ILE PRO ASN HIS SEQRES 54 A 800 GLU LYS ARG ALA GLY LYS LEU ASP ALA HIS LEU VAL LEU SEQRES 55 A 800 GLU GLN LEU ARG CYS ASN GLY VAL LEU GLU GLY ILE ARG SEQRES 56 A 800 ILE CYS ARG GLN GLY PHE PRO ASN ARG ILE VAL PHE GLN SEQRES 57 A 800 GLU PHE ARG GLN ARG TYR GLU ILE LEU ALA ALA ASN ALA SEQRES 58 A 800 ILE PRO LYS GLY PHE MET ASP GLY LYS GLN ALA CYS ILE SEQRES 59 A 800 LEU MET ILE LYS ALA LEU GLU LEU ASP PRO ASN LEU TYR SEQRES 60 A 800 ARG ILE GLY GLN SER LYS ILE PHE PHE ARG THR GLY VAL SEQRES 61 A 800 LEU ALA HIS LEU GLU GLU GLU ARG ASP LEU GLY SER ASP SEQRES 62 A 800 TYR LYS ASP ASP ASP ASP LYS HET 52E A 901 35 HET MG A 902 1 HET ADP A 903 27 HETNAM 52E 4-{[(2-CHLORO-3-FLUOROBENZYL)CARBAMOYL](METHYL)AMINO}- HETNAM 2 52E 3,4-DIDEOXY-5-O-(ISOQUINOLIN-3-YLCARBAMOYL)-D-ERYTHRO- HETNAM 3 52E PENTITOL HETNAM MG MAGNESIUM ION HETNAM ADP ADENOSINE-5'-DIPHOSPHATE FORMUL 2 52E C24 H26 CL F N4 O5 FORMUL 3 MG MG 2+ FORMUL 4 ADP C10 H15 N5 O10 P2 FORMUL 5 HOH *54(H2 O) HELIX 1 AA1 ASP A 73 ILE A 75 5 3 HELIX 2 AA2 PRO A 80 SER A 84 5 5 HELIX 3 AA3 ASP A 88 LEU A 92 5 5 HELIX 4 AA4 ASN A 96 SER A 110 1 15 HELIX 5 AA5 SER A 134 LYS A 142 1 9 HELIX 6 AA6 LYS A 145 MET A 149 5 5 HELIX 7 AA7 HIS A 152 ARG A 168 1 17 HELIX 8 AA8 GLY A 182 ALA A 198 1 17 HELIX 9 AA9 GLY A 218 LEU A 225 1 8 HELIX 10 AB1 GLN A 226 GLY A 235 1 10 HELIX 11 AB2 GLU A 273 ILE A 278 5 6 HELIX 12 AB3 PHE A 287 ALA A 297 1 11 HELIX 13 AB4 SER A 298 LEU A 305 1 8 HELIX 14 AB5 GLY A 309 TYR A 313 5 5 HELIX 15 AB6 GLN A 327 GLY A 343 1 17 HELIX 16 AB7 THR A 345 GLY A 363 1 19 HELIX 17 AB8 ASN A 381 GLY A 392 1 12 HELIX 18 AB9 ASN A 394 THR A 404 1 11 HELIX 19 AC1 THR A 419 ASP A 451 1 33 HELIX 20 AC2 SER A 476 ARG A 507 1 32 HELIX 21 AC3 ASP A 516 ASP A 520 5 5 HELIX 22 AC4 LEU A 521 ARG A 530 1 10 HELIX 23 AC5 GLY A 536 TRP A 546 1 11 HELIX 24 AC6 THR A 551 GLY A 564 1 14 HELIX 25 AC7 ALA A 596 ASP A 603 1 8 HELIX 26 AC8 ASN A 606 GLN A 615 1 10 HELIX 27 AC9 ASP A 618 TRP A 625 1 8 HELIX 28 AD1 THR A 658 ASN A 676 1 19 HELIX 29 AD2 ASP A 697 ASN A 708 1 12 HELIX 30 AD3 GLY A 709 GLN A 719 1 11 HELIX 31 AD4 PHE A 727 GLU A 735 1 9 HELIX 32 AD5 ASP A 748 ALA A 759 1 12 SHEET 1 AA1 4 LEU A 34 SER A 39 0 SHEET 2 AA1 4 GLY A 43 LYS A 53 -1 O ALA A 47 N VAL A 35 SHEET 3 AA1 4 GLU A 56 LEU A 61 -1 O THR A 58 N GLU A 51 SHEET 4 AA1 4 LYS A 67 SER A 71 -1 O VAL A 68 N VAL A 59 SHEET 1 AA2 7 TYR A 114 TYR A 116 0 SHEET 2 AA2 7 CYS A 121 ILE A 124 -1 O VAL A 122 N THR A 115 SHEET 3 AA2 7 ASN A 678 ILE A 685 1 O ILE A 685 N VAL A 123 SHEET 4 AA2 7 GLN A 171 THR A 176 1 N LEU A 174 O VAL A 682 SHEET 5 AA2 7 SER A 459 ASP A 465 1 O GLY A 462 N GLN A 171 SHEET 6 AA2 7 GLY A 249 PHE A 256 -1 N LYS A 250 O ASP A 465 SHEET 7 AA2 7 ILE A 262 TYR A 270 -1 O VAL A 263 N ASN A 255 SHEET 1 AA3 2 ASN A 236 ALA A 237 0 SHEET 2 AA3 2 SER A 245 SER A 246 -1 O SER A 245 N ALA A 237 SHEET 1 AA4 2 LYS A 368 LYS A 369 0 SHEET 2 AA4 2 ALA A 376 SER A 377 -1 O SER A 377 N LYS A 368 SHEET 1 AA5 2 ILE A 407 LYS A 408 0 SHEET 2 AA5 2 VAL A 413 VAL A 414 -1 O VAL A 414 N ILE A 407 SHEET 1 AA6 3 PHE A 569 GLN A 570 0 SHEET 2 AA6 3 GLU A 580 HIS A 585 -1 O CYS A 582 N GLN A 570 SHEET 3 AA6 3 GLY A 588 ASN A 593 -1 O TYR A 592 N PHE A 581 SHEET 1 AA7 3 ASN A 723 VAL A 726 0 SHEET 2 AA7 3 LYS A 773 PHE A 776 -1 O PHE A 776 N ASN A 723 SHEET 3 AA7 3 TYR A 767 ILE A 769 -1 N ARG A 768 O PHE A 775 LINK OG1 THR A 184 MG MG A 902 1555 1555 2.00 LINK OG SER A 246 MG MG A 902 1555 1555 2.11 LINK MG MG A 902 O2B ADP A 903 1555 1555 2.03 LINK MG MG A 902 O HOH A1003 1555 1555 2.07 LINK MG MG A 902 O HOH A1025 1555 1555 2.07 LINK MG MG A 902 O HOH A1042 1555 1555 2.17 CISPEP 1 THR A 778 GLY A 779 0 -11.59 SITE 1 AC1 17 MET A 89 ALA A 90 SER A 117 GLY A 118 SITE 2 AC1 17 LEU A 119 PHE A 120 PHE A 493 MET A 497 SITE 3 AC1 17 GLY A 709 VAL A 710 GLU A 712 GLY A 713 SITE 4 AC1 17 ILE A 714 CYS A 717 PRO A 722 ARG A 724 SITE 5 AC1 17 HOH A1001 SITE 1 AC2 6 THR A 184 SER A 246 ADP A 903 HOH A1003 SITE 2 AC2 6 HOH A1025 HOH A1042 SITE 1 AC3 17 ASN A 125 PRO A 126 TYR A 127 LYS A 128 SITE 2 AC3 17 TYR A 133 GLY A 180 ALA A 181 GLY A 182 SITE 3 AC3 17 LYS A 183 THR A 184 GLU A 185 ASN A 242 SITE 4 AC3 17 MG A 902 HOH A1003 HOH A1010 HOH A1025 SITE 5 AC3 17 HOH A1033 CRYST1 73.190 202.970 67.560 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013663 0.000000 0.000000 0.00000 SCALE2 0.000000 0.004927 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014802 0.00000